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A B S T R A C T
The APOE-ε4 genotype is the highest genetic risk factor for Alzheimer's disease (AD). In cognitively unimpaired
individuals, it has been related to altered brain morphology, function and earlier amyloid beta accumulation.
However, its impact on cognitive performance is less evident. Here, we examine the impact of APOE-ε4 allele
load in modulating the association between cognitive functioning and brain morphology in middle-aged healthy
individuals. A high-resolution structural MRI scan was acquired and episodic memory (EM) as well as executive
functions (EFs) were assessed in a sample of 527 middle-aged unimpaired individuals hosting a substantial
representation of ε4-homozygous (N=64). We adopted a voxel-wise unbiased method to assess whether the
number of APOE-ε4 alleles significantly modified the associations between gray matter volumes (GMv) and
performance in both cognitive domains.
Even though the APOE-ε4 allele load did not exert a direct impact on any cognitive measures, it reversed the
relationships between GMv and cognitive performance in a highly symmetrical topological pattern. For EM,
interactions mapped onto the inferior temporal gyrus and the dorsal anterior cingulate cortex. Regarding EFs,
significant interactions were observed for processing speed, working memory, and visuospatial attention in
distinct brain regions. These results suggest that APOE-ε4 carriers display a structure-function association cor-
responding to an older age than their chronological one. Our findings additionally indicate that APOE-ε4 carriers
may rely on the integrity of multiple compensatory brain systems in order to preserve their cognitive abilities,
possibly due to an incipient neurodegeneration. Overall this study provides novel insights on the mechanisms
through which APOE-ε4 posits an increased AD risk.
1. Introduction
Alzheimer's disease (AD) is a severe neurodegenerative disorder
characterized by diffuse brain atrophy along with progressive decline in
multiple cognitive domains. In recent years, the pathophysiological
model of AD has been redefined along a disease continuum where the
neuropathological changes, such as cerebral amyloid beta (Aβ)
deposition, have been shown to precede any detectable cognitive
manifestation by two or three decades (Sperling et al., 2014). There-
fore, tremendous effort has been made in order to elucidate the link
between the pathological cascade of AD and the emergence of cognitive
symptoms (Jack Jr. et al., 2018).The APOE-ε4 allele represents the
major genetic risk factor for sporadic AD by lowering the age of onset in
a gene dose-dependent manner (Liu et al., 2013). APOE-ε4 codes the
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apolipoprotein-ε4 (apoE4), which compared to other isoforms, is less
effective in maintaining cerebral lipid homeostasis and in breaking
down amyloid beta (Aβ) peptide, thus facilitating the formation of
extracellular insoluble oligomers (Zhao et al., 2017). Cognitively intact
APOE-ε4 carriers show higher cerebral Aβ deposition (Jansen et al.,
2015; Reiman et al., 2009) as well as lower cerebral metabolism
(Reiman et al., 2005), with these effects being proportional to the
number of ε4 alleles. Previous studies have also reported an impact of
the risk variant on cerebral morphology in healthy individuals
(Alexander et al., 2012; Honea et al., 2009; Ten Kate et al., 2016) al-
though this has not always been confirmed (Protas et al., 2013;
Mondadori et al., 2007; Gonneaud et al., 2016; see Fouquet et al., 2014
for a review). Recently, using a spatially unbiased voxel-wise approach
in a sample harboring a high number of healthy APOE-ε4 homozygous,
we have reported dose–dependent effects of the risk allele on the vo-
lume of several AD-sensitive areas (Cacciaglia et al., 2018a). Yet, the
underlying mechanisms through which APOE-ε4 posits increased risk
for AD are not fully understood, and its impact on cognitive perfor-
mance in unaffected individuals remains unclear. Previous seminal
works reported a gene dose-dependent lifetime decline in episodic
memory (EM) (Caselli et al., 2009) but not in executive functions (EFs)
(Caselli et al., 2011) in cognitively unimpaired APOE-ε4 carriers com-
pared to non-carriers, even though other studies could not confirm such
a longitudinal association (Bunce et al., 2014). Similarly, cross-sec-
tional studies reported either worse (Nao et al., 2017; Honea et al.,
2009), better (Mondadori et al., 2007), or equivalent (Matura et al.,
2016; Reiman et al., 2004) cognitive functioning in healthy carriers of
the risk allele compared to non-carriers. Divergence among studies may
depend on the age of the participants (Jochemsen et al., 2012) as well
as the amyloid status, since the detrimental impact of APOE-ε4 in
healthy individuals has been shown to occur in Aβ-positive individuals
only (Lim et al., 2018).
Besides genetic liability, the greatest unmodifiable AD risk factor is
represented by advanced age. Recently we have reported that, irre-
spective of the APOE status, aging modulates the relationship between
cognitive performance (i.e., both EM and EFs) and regional brain vo-
lumes in healthy participants, with older individuals displaying re-
versed associations compared to younger ones in medial temporal and
prefrontal areas (Cacciaglia et al., 2018b). Since APOE-ε4 has been
proposed to confer an accelerated aging process (Cacciaglia et al.,
2018a; Evans et al., 2014; Filippini et al., 2011), one possibility is that,
although not significantly affecting cognitive performance in the
healthy population, the ε4 allele would modify the association between
cognitive performance and the underlying brain morphology in a si-
milar way as exerted by aging. This assumption is also supported by
earlier functional neuroimaging studies which showed that APOE-ε4
modulates the relationship between cognitive performance and patterns
of brain activity (Matura et al., 2016; Evans et al., 2014; Filippini et al.,
2011; Bondi et al., 2005; Bookheimer et al., 2000) as well as cerebral
Aβ deposition in healthy individuals (Kantarci et al., 2012).
In the present study we sought to determine whether this mod-
ulatory role is extendable to the brain structural level. We predicted
that APOE-ε4 would shift the associations between regional GMv and
cognitive performance in both EM and EFs. We tested our hypotheses
on a sample of middle-aged cognitively healthy individuals which was
enriched for the genetic risk for AD, hosting a significantly higher
number of APOE-ε4 homozygous than previously reported in single-site
neuroimaging studies of healthy subjects (N=64). This sample char-
acteristic allowed us testing separate genotypic models which may
capture distinct biological pathways for the risk allele to confer AD
liability, as previously suggested in structural neuroimaging studies of




All subjects were enrolled in the ALFA (ALzheimer and FAmilies)
study (Clinicaltrials.gov Identifier: NCT01835717), a large cohort pro-
gram pointing to the identification of pathophysiological alterations in
preclinical AD comprising 2743 study participants (Molinuevo et al.,
2016). Participants were cognitively unimpaired with a Clinical De-
mentia Rate score of 0. Subjects with disorders which could interfere
with cognition or with a psychiatric diagnosis were excluded from the
study. Additional exclusion criteria have been described in detail pre-
viously (Molinuevo et al., 2016). After APOE genotyping, all partici-
pants homozygous for the ε4 allele as well as carriers of the ε2 allele
were invited to undergo magnetic resonance imaging (MRI) scanning
along with ε4-heterozygous and non-carriers matched for age and sex.
This recruitment strategy resulted in 576 study participants, out of
which 43 had to be discarded due to MRI incidental findings or poor
image quality. From the remaining 533 individuals, 6 subjects were
discarded due to missing cognitive data, yielding to a final sample of
527 subjects. For the statistical analyses participants were pooled ac-
cording to the cumulative presence of the ε4 allele, that is in non-car-
riers (NC), ε4-heterozygous (HE) and ε4-homozygous (HO). The study
was approved by the local ethics committee, and all participants gave
written informed consent to participate in the study.
2.2. APOE genotyping
Total DNA was obtained from blood cellular fraction by proteinase
K digestion followed by alcohol precipitation. Samples were genotyped
for two single nucleotide polymorphisms (SNPs), rs429358 and rs7412,
determining the possible APOE isoforms: ε1, rs429358 (C)+ rs7412
(T); ε2, rs429358 (T)+ rs7412 (T); ε3, rs429358 (T)+ rs7412 (C); and
ε4, rs429358 (C)+ rs7412 (C). Of the 527 participants, 162 were ε3/ε4
carriers, 149 were homozygous for the ε3 allele, 104 were ε2/ε3 car-
riers, 64 were homozygous for the ε4 allele, 42 were ε2/ε4, and 6 were
ε2/ε2 carriers. The allele frequencies did not significantly deviate from
Hardy-Weinberg equilibrium (χ2= 5.99, p= .20).
2.3. Image data acquisition and preprocessing
Magnetic resonance imaging (MRI) was conducted with a 3 T
General Electric scanner (GE Discovery MR750 W). Structural 3D high-
resolution T1-weighted images were collected using a fast spoiled gra-
dient-echo (FSPGR) sequence implementing the following parameters:
voxel size= 1mm3 isotropic, Repetition Time (TR)= 6.16ms, Echo
Time (TE)= 2.33ms, inversion time (TI)= 450ms, matrix
size= 256×256×174, flip angle= 12°. Gray matter (GM) was seg-
mented from images using the new segment function implemented in
Statistical Parametrical Mapping software (SPM 12, Wellcome
Department of Imaging Neuroscience, London, UK), and located into a
common space for subsequent normalization using a 12-affine para-
meter transformation. Segmented GM images were used to generate a
reference template of the sample, which was warped into a standard
Montreal Neurological Institute (MNI) space using the high dimensional
DARTEL toolbox (Ashburner, 2007). The generated flow fields and
normalization parameters were then implemented to normalize the
native GM images to the MNI space. In order to preserve the native local
amount of GM volume, we applied a modulation step, where each voxel
signal's intensity was multiplied by the Jacobian determinants derived
from the normalization procedure (Good et al., 2001). Quality control
of normalization was assured by checking the sample homogeneity with
the computational anatomy toolbox (CAT12) (http://dbm.neuro.uni-
jena.de/cat/) using non-smoothed data, which did not return errors in
the registration procedure in any subject. Finally, images were spatially
smoothed with a 6mm full-width at half maximum (FWHM) Gaussian
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kernel. Total intracranial volume (TIV) was computed by summing the
segmented GM, white matter (WM) and cerebrospinal fluid (CSF) vo-
lumes for each individual.
2.4. Neuropsychological evaluation
The neuropsychological assessment took place on average
10.6months (SD=5.81) before the MRI session. EM was assessed using
the Spanish adapted version of the Memory Binding Test (MBT)
(Gramunt et al., 2016), an instrument that was developed for detecting
subtle memory impairment in the cognitively intact population
(Buschke, 2014). Previous studies have demonstrated the ability of the
MBT (formerly referred as Memory Capacity Test [MCT]) to dis-
criminate subjects with cerebral Aβ deposition (Papp et al., 2015), and
to successfully predict the incidence of MCI longitudinally (Mowrey
et al., 2016). During administration, subjects sequentially learn two
lists of 16 words written in cards, where each card contains four words.
The lists share semantic categories, which are used both to control the
encoding of the words in learning and as cues during cued recall trials.
After the presentation of each list, immediate cued recall (CR) of the
presented items is tested, to provide a measure of successful encoding.
Four main outcomes are produced: Total Paired Recall (TPR), which is
the recall of both lists after semantic cueing; Total Free Recall (TFR), for
the free recall of both lists; Total Delayed Paired Recall (TDPR), for the
delayed (30min after initial recall) after semantic cueing; and Total
Delayed Free Recall (TDFR), for the delayed counterpart of the free
recall. As a measure of cued memory retention, we computed the per-
centage of loss of learnt words over to two different time-laps. This was
achieved by dividing TPR and TDPR scores by scores for immediate
cued recall (CR), respectively. This procedure generated two different
retention index scores: short-delay retention (SDR) and long-delay re-
tention (LDR). The former (SDR) covered a time-lap of approximately
5min (i.e., the time between the end of CR and the last recalled word in
TPR), while the latter (LDR) covered a lap of approximately 30min (i.e.,
the time between the end of CR and the last recalled word in TDPR).
EFs were assessed using the Wechsler Adult Intelligence Scale-
Fourth Edition (WAIS-IV, Wechsler, 2012). We administered five
subtests: Coding (cognitive processing speed), Digit Span (working
memory), Matrix Reasoning (non-verbal problems solving), Visual
Puzzles (visuospatial processing), and Similarities (verbal reasoning
and abstract thinking). Digit Span subtests were studied separately as
previously recommended (Colom et al., 2007) (Digit-span forward,
Digit-span backward, Digit-span sequencing).
2.5. Statistical analysis
Group differences in demographic variables were assessed with a
one-way analysis of variance or a chi-squared test for continuous or
categorical variables, respectively.
To assess group differences in cognitive performance we conducted
an analysis of covariance (ANCOVA) separately for each outcome,
where APOE-ε4 status was entered as a between-subject factor, while
age, sex and years of education were modelled as covariates. Since
APOE-ε4 influences the age-related cognitive decline in healthy
individuals (Caselli et al., 2009, 2011), we further modelled the inter-
action between APOE status and age. Statistical threshold for sig-
nificance was set to α < 0.05. Structural imaging data were analyzed
using Statistical Parametric Mapping software (SPM12, Wellcome De-
partment of Imaging Neuroscience, London, UK). The normalized,
modulated and smoothed GM images were entered in a multiple re-
gression design within the general linear model (GLM) implemented in
SPM12. To determine the structural brain correlates of EM and EFs in
the entire sample, we modelled the effect of each cognitive outcome
separately, further controlling for the effects of age, sex, years of edu-
cation and TIV. To assess the impact of APOE-ε4 in modulating the
relationship between cognitive performance and regional GMv, we
performed a separate GLM, where the variability in cognitive perfor-
mance was modelled separately for each APOE-ε4 subgroup, namely
non-carriers (NC), ε4-heterozygous (HE) and ε4-homozygous (HO). This
procedure resulted in the inclusion of 3 orthogonal regressors coding
the interaction between APOE status and cognitive performance. Next,
different t-contrasts were performed to test the distinct models of ge-
netic penetrance, namely the dominant, recessive and additive effects,
as proposed for the analysis of quantitative trait loci (Clarke et al.,
2011). Briefly, an additive model predicts an incremental response of
the quantitative trait according to the allelic load, whereas a dominant
model predicts a common response to 1 or 2 copies of the risk allele
(i.e., ε4-carriers vs. non-carriers). Finally, a recessive model predicts a
common response to 0 or 1 copy of the risk allele (i.e., non-carriers and
ε4-heterozygotes vs. ε4-homozygotes). This approach was already im-
plemented in neuroimaging studies investigating the impact of the
APOE genotype on brain morphology (Cacciaglia et al., 2018a; Filippini
et al., 2009). Results were considered significant if surviving a whole-
brain voxel-wise statistical threshold of p < .001 applying a cluster
extent threshold correction of 100 contiguous voxels. This procedure is
reliably conservative and further protects against Type I error (Gispert
et al., 2015).
Finally, to reduce dimensionality and to search for common patterns
of brain morphology associated to EM and EFs, we additionally per-
formed a principal component analysis (PCA) separately for the two
cognitive domains and repeated all the above analyses using the ex-
tracted principal components as dependent variables (Gaskin and
Happell, 2014).
3. Results
3.1. Sample demographic characteristics
Table 1 summarizes the demographic characteristics of our sample.
The APOE genotype groups did not differ in TIV, male/female ratio, or
years of education. There was, however, a significant difference in age
with the ε4-homozygous being younger than both non-carriers and ε4-
heterozygous. For this reason, age was included as covariate in all
subsequent analyses.
3.2. APOE genotype and cognitive performance
Table 2 displays main effects of our independent predictors (i.e.,
Table 1
Sample demographic characteristics.
NC (N=259) HE (N=204) HO (N=64) Inferential statistics
Agea (SD) 57.97 (7.55) 58.23 (7.45) 53.97 (6.07) F=8.85; P < .01
Educationa (SD) 13.68 (3.62) 13.68 (3.53) 13.44 (3.46) F=0.13; P= .88
TIVb (SD) 1448.75 (155.75) 1496.64 (137.84) 1493.82 (136.26) F=0.39; P= .67
Male/female (n) 95/164 93/111 24/40 χ2= 3.99; P=.14
TIV: Total intracranial volume; NC: Non-Carriers; HE: ε4-heterozygous; HO: ε4-homozygous.
a Indicated in years.
b Indicated in Cm3.
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APOE-ε4, age, sex, and years of education) as well as the interaction
between APOE-ε4 and age on cognitive performance in EM and EFs.
None of the three genotypic models yielded significant main effects of
APOE-ε4 on EM or EFs performance. Irrespective of the genetic model
of penetrance, immediate as well as delayed recall performance sig-
nificantly declined with increasing age, however both short- and long-
delay retention did not show an age-related decline (Table 2; Supple-
mentary Fig. 3). All measures of EFs showed a significant age-related
effect except the digit-span forward and digit-span backward (Table 2).
Additionally, while female subjects performed better in recall perfor-
mance, males obtained significantly higher scores in EFs (Table 2;
Supplementary Fig. 3). A confirmatory analysis performed on the first
principal component for each cognitive domain yielded similar results
(Supplementary Table 1).
3.3. Impact of APOE-ε4 on the associations between EM performance and
GMv
Supplementary Table 2 displays the brain volumetric correlates of
cognitive performance in the whole sample, which are in line with our
previous study conducted on a subsample of the present one (Cacciaglia
et al., 2018b). We detected significant interactions between EM per-
formance and APOE status in all the MBT outcomes, indicating that
APOE-ε4 significantly modified the relationships between EM
proficiency and gray matter morphology (Table 3). Figs. 1 and 2 display
these effects in selected brain regions separately for paired and free
recall. The dominant, recessive and additive models mapped onto
shared brain areas, such as the inferior temporal gyrus, the dorsal
anterior cingulate cortex as well as the cuneus for the TFR, and the
basal forebrain cholinergic nuclei for the TDPR. For TDFR, the recessive
and the additive models shared several regions including the inferior
superior temporal cortex, the precuneus and the posterior cingulate
gyrus. The shared topology among different genotypic contrasts in some
areas does not assure that variability in that specific region is equally
summarized by those contrasts. To provide statistical evidence of this,
we performed a conjunction analysis in SPM asking for all common
brain regions in pairs of t-contrasts (i.e., dominant-recessive, dominant-
additive, recessive-additive). Results show that for most cognitive
outcomes, there are no shared brain regions between the dominant and
the recessive models (Supplementary Table 3). Table 4 and Fig. 3 il-
lustrate significant interaction effects for short as well as long-delay
retention index (SDR, LDR). In both retention indices, there were no
shared brain regions between the dominant and the recessive models,
suggesting that these two genotypic models captured distinct biological
mechanisms. For SDR, the dominant and the additive models revealed
significant interactions in the right and left hippocampus as well as the
bilateral insula and the posterior cingulate, with these effects ad-
ditionally surviving correction for multiple testing on the cluster level
Table 2
Cognitive performance in the whole sample assessed for each subtest.
APOE-ε4 status Age(y) APOE x Age Sex Education(y)
F P F P F P F P F P
Dominant model TPR 2.99 0.08 11.35 < 0.01 2.41 0.12 4.33 0.04 20.44 < 0.01
TFR 2.35 0.12 35.77 < 0.01 2.22 0.13 6.01 0.02 12.18 < 0.01
TDPR 1.81 0.18 11.48 < 0.01 1.35 0.24 4.96 0.03 21.58 < 0.01
TDFR 0.65 0.42 39.06 < 0.01 0.39 0.53 5.51 0.02 39.06 < 0.01
SDR 0.01 0.93 3.29 0.07 0.01 0.95 3.47 0.06 10.83 < 0.01
LDR 0.11 0.73 2.27 0.13 0.16 0.68 6.46 0.01 11.72 < 0.01
Coding 0.19 0.67 118.7 < 0.01 0.13 0.71 0.94 0.33 67.24 < 0.01
DSF 0.01 0.97 2.37 0.12 0.02 0.88 25.57 < 0.01 24.80 < 0.01
DSB 0.86 0.35 6.76 0.01 0.69 0.40 17.04 < 0.01 32.10 < 0.01
DSS 0.38 0.53 16.74 < 0.01 0.36 0.55 23.31 < 0.01 33.51 < 0.01
Matrix 0.83 0.36 52.93 < 0.01 0.83 0.36 5.10 0.02 94.25 < 0.01
Similarities 0.32 0.57 8.25 < 0.01 0.23 0.62 8.97 < 0.01 126.4 < 0.01
VP 0.33 0.56 40.31 < 0.01 0.26 0.61 47.88 < 0.01 43.70 < 0.01
Recessive model TPR 0.99 0.32 0.56 0.45 1.39 0.23 3.87 0.05 20.25 < 0.01
TFR 0.01 0.94 9.05 < 0.01 0.04 0.84 5.74 0.01 12.23 < 0.01
TDPR 1.14 0.28 0.52 0.46 1.54 0.21 4.52 0.03 21.42 < 0.01
TDFR 0.01 0.94 9.98 < 0.01 0.04 0.83 5.00 0.02 17.07 < 0.01
SDR 2.71 0.10 0.04 0.82 2.47 0.11 3.48 0.06 10.34 < 0.01
LDR 0.62 0.43 0.20 0.65 0.40 0.52 6.48 0.01 11.18 < 0.01
Coding 0.86 0.35 26.01 < 0.01 0.98 0.32 1.10 0.29 67.64 < 0.01
DSF 1.81 0.17 0.18 0.67 2.13 0.14 26.43 < 0.01 24.68 < 0.01
DSB 0.15 0.69 0.66 0.41 0.33 0.56 17.77 < 0.01 32.49 < 0.01
DSS 0.10 0.74 4.85 0.03 0.02 0.89 23.89 < 0.01 34.37 < 0.01
Matrix 0.02 0.88 16.07 < 0.10 0.01 0.93 5.06 0.02 94.80 < 0.01
Similarities 0.37 0.54 1.21 0.27 0.36 0.54 9.27 < 0.01 125.2 < 0.01
VP 0.13 0.71 13.16 < 0.01 0.08 0.77 47.57 < 0.01 44.49 < 0.01
Additive model TPR 2.44 0.08 2.75 0.08 2.43 0.08 4.54 0.03 20.50 < 0.01
TFR 1.06 0.34 17.67 < 0.01 1.09 0.33 5.94 0.01 12.28 < 0.01
TDPR 1.87 0.15 2.54 0.10 1.88 0.15 5.09 0.02 21.63 < 0.01
TDFR 0.26 0.77 19.01 < 0.01 0.20 0.81 5.42 0.02 17.14 < 0.01
SDR 1.71 0.18 0.21 0.64 1.50 0.22 3.86 0.05 10.41 < 0.01
LDR 0.34 0.71 0.80 0.37 0.21 0.80 6.89 < 0.01 11.23 < 0.01
Coding 0.47 0.62 52.09 < 0.01 0.50 0.61 0.94 0.33 67.32 < 0.01
DSF 0.98 0.37 0.01 0.91 1.11 0.33 25.21 < 0.01 24.75 < 0.01
DSB 0.43 0.64 1.94 0.16 0.50 0.60 17.16 < 0.01 32.47 < 0.01
DSS 0.08 0.92 8.36 < 0.01 0.05 0.95 23.86 < 0.01 34.22 < 0.01
Matrix 0.64 0.52 27.42 < 0.01 0.61 0.54 5.26 0.02 94.53 < 0.01
Similarities 0.57 0.56 3.21 0.07 0.49 0.61 8.65 < 0.01 125.2 < 0.01
VP 0.51 0.59 21.67 < 0.01 0.39 0.67 48.57 < 0.01 44.28 < 0.01
TPR: Total paired recall; TFR: Total free recall; TDPR: Total delayed paired recall; TDFR: Total delayed free recall; SDR: Short-delay retention; LDR: Long-delay
retention; DSF: Digit-span forward; DSB: Digit-span backwards; DSS: Digit-span sequence; VP: Visual Puzzles.
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Table 3
APOE-ε4 significantly modulated the relationship between EM performance and regional GMv.




ε4-dominant Middle frontal R 4.55 135 33 29 33
Dorsal anterior cingulate L 4.46 290 −9 27 36
Insulaa L 4.29 618 −35 −14 14
Precuneus L 4.00 316 0 −56 32
Insula R 4.00 299 41 −11 11
Basal forebrain R 3.97 103 15 −3 −12
Frontal operculum R 3.96 105 41 15 12
Basal forebrain L 3.86 365 −9 3 −15
ε4-recessive Posterior cingulate L 3.71 127 0 −41 24
ε4-additive Middle frontal R 4.61 104 33 29 33
Insula L 4.14 249 −38 −11 9
Dorsal anterior cingulate R 4.12 182 −9 29 36
Posterior cingulate L 3.89 295 0 −41 24
Orbitofrontal gyrus L 3.82 100 −9 51 −29
Basal forebrain L 3.63 236 −11 3 −17
TFR
ε4-dominant Dorsal anterior cingulate L 4.56 278 −9 27 35
Cuneus R 4.34 204 20 −71 21
Inferior Temporal L 4.27 270 −54 −39 −17
Superior temporal L 4.23 304 −39 −17 −3
Insula R 4.14 415 39 −11 9
Insulaa L 4.02 479 −36 −2 9
Precuneus R 3.98 207 9 −45 17
Angular gyrus R 3.84 126 29 −56 42
Rectus L 3.84 113 −6 17 −24
Basal forebrain L 3.73 136 −11 5 −12
Rectus L 3.63 222 −6 45 −20
ε4-recessive Inferior temporal R 4.88 227 57 −44 −14
SMA R 4.43 353 5 12 56
Cuneus R 4.12 136 18 −74 24
Middle cingulate L 3.86 228 −8 −3 36
Precuneusa L 3.80 496 −3 −62 29
Paracentral lobule L 3.75 158 −8 −26 57
Dorsal anterior cingulate L 3.63 125 −9 27 35
Precuneus L 3.57 104 −11 −48 11
Cerebellum lob. 6 R 3.44 141 30 −63 −21
ε4-additive Inferior temporal R 4.74 219 57 −45 −12
Cuneus R 4.53 207 20 −72 23
Dorsal anterior cingulatea L 4.39 529 −9 27 35
Inferior temporal L 4.12 120 −53 −39 −17
SMA R 4.10 292 3 11 57
Middle occipital gyrus L 4.08 112 −47 −78 −2
Posterior cingulatea L 4.01 1063 0 −54 30
Insula L 3.88 212 −36 −20 −5
Entorhinal cortex R 3.85 130 23 −2 −36
Basal forebrain L 3.66 100 −11 3 −17
TDPR
ε4-dominant Dorsal anterior cingulate L 4.38 329 −9 27 36
Precuneus L 4.16 135 0 −56 32
Middle fontal gyrus R 4.15 104 33 29 33
Rolandic operculum L 4.14 442 −39 −9 9
Insula R 4.00 204 39 −11 9
Frontal operculum R 3.98 199 41 15 12
Basal forebraina L 3.95 480 −11 3 −17
Fusiform gyrus L 3.66 190 −35 −11 −41
ε4-recessive SMA R 4.49 167 5 12 54
Frontal operculum R 3.86 107 42 14 11
Dorsal anterior cingulate L 3.66 110 −9 29 36
Basal forebrain L 3.38 123 −3 14 −15
ε4-additive SMA R 4.37 170 6 12 54
Frontal operculum R 4.20 166 41 15 12
Dorsal anterior cingulate L 4.20 316 −9 27 36
Insula L 4.00 172 −38 −11 11
Basal forebraina L 4.00 523 −11 3 −17
Insula R 3.91 103 41 −11 9
TDFR
(continued on next page)
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(using a family-wise error rate [FWE] approach). For LDR, the domi-
nant model yielded significant effects in the middle and posterior cin-
gulate cortex as well as the bilateral insula and the inferior parietal
cortex. By contrast, the recessive model mapped onto different regions,
such as the entorhinal cortex as well as the superior frontal cortex and
the cerebellum (lobule 8). In all brain regions APOE-ε4 carriership
shifted the association between EM performance and regional GMv
from being negative to positive (Figs. 1–3).
Table 3 (continued)
Brain region Laterality t-value⁎ k⁎⁎ MNI coordinates
x y z
ε4-dominant Basal forebrain L 4.20 288 −11 3 −15
Insula R 4.08 446 38 −12 −3
Caudate nucleus R 4.02 358 3 6 2
Insula L 3.95 106 −32 −3 15
Superior temporala L 3.94 486 −39 −17 −3
ε4-recessive Inferior temporala R 4.77 173 57 −44 −14
SMA R 4.28 300 6 12 56
Dorsal anterior cingulate R 3.89 130 0 32 32
Precuneus L 3.82 122 −3 −63 30
Posterior cingulate R 3.60 272 9 −38 30
Precuneus R 3.58 172 12 −47 11
ε4-additive Inferior temporal R 4.24 109 57 −45 −12
Dorsal anterior cingulate L 4.11 179 0 32 32
SMA R 4.05 262 8 12 54
Basal forebrain L 3.96 193 −11 3 −17
Precuneus L 3.94 223 −3 −63 30
Insula L 3.79 172 −36 −20 −5
Posterior cingulate R 3.33 107 8 −44 24
MNI: Montreal Neurological Institute; TPR: Total paired recall; TFR: Total free recall; TDPR: Total delayed paired recall; TDFR: Total delayed free recall; SMA:
Supplementary motor area.
⁎ Significant at a whole-brain threshold of p < .001, with a cluster size correction of 100 contiguous voxels.
⁎⁎ Cluster size indicated in number of contiguous voxels.
a Additionally survived correction for multiple testing on the cluster level (p < .05) computed with a Family-Wise Error rate approach (FWE).
Fig. 1. APOE-ε4 risk variant modulated the associations between paired recall and gray matter volume.
A) and B) Voxel-wise volumetric maps showing the dominant, recessive and additive effects of APOE-ε4 in modulating the association between immediate as well as
delayed paired recall (TPR, TDPR) and gray matter structure For visualization purposes parametric maps are thresholded at p < .005 with a cluster extent threshold
of 100 voxels. C) and D) Group scatterplots in selected brain regions showing the significant interactions between immediate as well as delayed paired recall
performance (TPR, TDPR) and APOE-ε4 status. Values of gray matter volume were extracted on the voxel level (cluster's local maximum) and adjusted for the
covariates in the model (i.e., age, sex, years of education and total intracranial volume). Pearson's correlation coefficients are shown on top of scatterplots for each
subgroup. *p < .05, **p < .01, two-tailed. Shaded areas indicate 90% confidence intervals. ACC: Anterior cingulate cortex; BFCN: Basal forebrain cholinergic
nuclei; PCC: Posterior cingulate cortex.
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3.4. Impact of APOE-ε4 on the associations between EFs performance and
GMv
APOE-ε4 modulated the association between GMv and efficiency in
EFs. Of the administered tests, we detected significant interactions for
the Coding, digit-span sequencing and the Visual Puzzles (Table 5).
Fig. 4 displays these effects in selected brain regions. For the Coding
test, the three genotypic models yielded significant effects in a set of
common brain regions including the lateral as well as medial orbito-
frontal cortex and the precentral gyrus. For the digit-span sequencing,
we observed significant effects in the caudate nucleus (both recessive
and additive models) and the middle orbital gyrus (recessive model).
Finally, for the VP, significant interaction effects were observed in the
postcentral gyrus (both recessive and additive models) and the superior
frontal cortex (additive model).
The direction of these interaction effects was opposite compared to
that observed for EM (i.e., APOE-ε4 shifted the relationships from being
positive to negative). A confirmatory analysis performed on the first
principal component for both EM and EFs yielded similar results
(Supplementary Table 4).
4. Discussion
We report that the APOE genotype modifies the association between
cognitive performance and the underlying cerebral morphology as ex-
pressed by regional GMv, in cognitively healthy individuals. In both
domains of EM and EFs, APOE-ε4 carriers displayed reversed relation-
ships between regional brain volumes and cognitive performance in a
highly symmetrical topological pattern. More specifically, presence of
APOE-ε4 shifted the associations between EM and regional GMv from
negative to positive, while driving the opposite effect on the
relationship with EFs. These effects resemble those observed in our
previous study, where we reported a qualitatively similar modulatory
role for aging in modifying the structure-function relationship
(Cacciaglia et al., 2018b). In our earlier report, we found that older age
shifted the association between GMv and EM performance from being
negative to positive, corroborating findings by other research groups
(Van Petten, 2004).We proposed that, while for younger individuals
reduced brain volumes in dedicated brain areas may be the result of
successful neurodevelopmental events which increase efficiency (e.g.,
synaptic pruning), larger GMv in advanced age would represent a proxy
for available brain reserve, therefore supporting memory performance.
Following this postulate, the results of the present study suggest that
APOE-ε4 carriers display a pattern of structure-function association
corresponding to an older age than their chronological one. If so, our
data would provide a biological underpinning for the hypothesis that
APOE-ε4 confers an accelerated aging process in the brain (Cacciaglia
et al., 2018a; Evans et al., 2014; Filippini et al., 2011). In line with this,
longitudinal studies reported a faster age-related decline of episodic
memory in unimpaired APOE-ε4 carriers, with a gene-dose dependent
effect (Caselli et al., 2009). Alternatively, our interaction data may be
indicative of age-independent neurodevelopmental effects of the ε4
allele on the brain morphology (Dean 3rd et al., 2014; Chang et al.,
2016), which may lead to a distinctive cerebral organization supporting
cognitive functioning during the entire lifespan. Additionally, it may be
that a proportion of our ε4-homozygous individuals have already en-
tered the preclinical stage of AD, with the pathology possibly affecting
the structural network underlying cognition. This latter consideration
remains however uncertain given the lack of core AD biomarkers in the
current study.
The dissociation we found between cerebral volumes and perfor-
mance in EM vs. EFs resembles that of our former study conducted in a
Fig. 2. APOE-ε4 risk variant modulated the associations between free recall and gray matter volume.
A) and B) Voxel-wise volumetric maps showing the dominant, recessive and additive effects of APOE-ε4 in modulating the association between delayed free recall
(TFR, TDFR) and gray matter structure. For visualization purposes parametric maps are thresholded at p < .005 with a cluster extent threshold of 100 voxels. C) and
D) Group scatterplots in selected brain regions showing the significant interactions between immediate as well as delayed paired recall performance (TFR, TDFR) and
APOE-ε4 status. Values of gray matter volume were extracted on the voxel level (cluster's local maximum) and adjusted for the covariates in the model (i.e., age, sex,
years of education and total intracranial volume). Pearson's correlation coefficients are shown on top of scatterplots for each subgroup. *p < .05, **p < .01, two-
tailed. Shaded areas indicate 90% confidence intervals. PCC: Posterior cingulate cortex.
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subsample of the present one, where we observed negative relation-
ships for EM but positive correlations for EFs (Cacciaglia et al., 2018b).
This divergence is reconciled if one considers that the brain structures
supporting EM (i.e., medial temporal lobe) and EFs (prefrontal cortex)
display different time-course maturation patterns, with medial tem-
poral lobe rapidly evolving during childhood, while prefrontal areas
reaching complete maturation only in the adulthood (Ghetti and Bunge,
2012). Therefore, compared to prefrontal areas, medial temporal lobe
regions may be more subject to neurodevelopmental events such as
synaptic pruning, which optimize neural computational efficiency (Tau
and Peterson, 2010). Besides, the observed dissociation on the brain
structure level, was already reported in functional MRI studies which
have observed deactivation in “task-negative” networks during suc-
cessful encoding (Kim et al., 2010), while observing an increase of
activation in the executive control network supporting EFs (Murphy
et al., 2018).
In the analysis of EM, we found that the three genotypic models
mapped onto common brain regions, such as the dorsal anterior cin-
gulate and the inferior temporal gyrus. However, for TPR and TDFR
there were no shared brain regions between the dominant and the re-
cessive models. The same was true for SDR and LDR, indicating that
these two models were associated to distinct brain structural imaging
phenotypes. Across all the MBT outcomes, the additive model, which
assumes an increased genetic penetrance according to the number of
risk alleles, yielded significant effects in the right and left basal fore-
brain cholinergic nuclei (BFCN) (Zaborszky et al., 2008). These consist
of four nuclei which provide the major cholinergic source to the hip-
pocampus and prefrontal areas (Mesulam, 2004). Cholinergic signaling
in the CNS ensures cortical activation, promotes vigilance, and supports
cognitive effort during attentional tasks (Ballinger et al., 2016). Im-
portantly, BFCN undergo progressive degeneration during the course of
AD (Teipel et al., 2005) and previous studies detected BCFN atrophy
prior to the onset of cognitive symptoms in healthy individuals who
later converted to AD (Schmitz et al., 2016; Grothe et al., 2013; Hall
et al., 2008). Additionally, Hanyu et al. (2002) reported that the
thickness of the BFCN positively correlated with global cognition in AD,
but not in other forms of dementia, suggesting that cognitive dysfunc-
tion in AD is at least partially attributable to cholinergic dysfunction.
Similarly, George et al. (2011) reported significantly positive associa-
tions in mild cognitive impairment (MCI) and AD patients, between
BFCN volume and immediate as well as delayed recall assessed using a
similar memory paradigm as ours. Hence our results suggest that, un-
like in non-carriers, EM efficiency in individuals at higher genetic risk
for AD depends on the integrity of brain structures which overlap with
those in AD patients, although being within normal ranges. Im-
portantly, an abnormal pattern of age-related BCFN structural degen-
eration has been shown to parallel Aβ positivity in cognitively healthy
people (Schmitz et al., 2018). Thus, it may be that among our healthy
ε4-homozygous, those having lower BFCN volumes and consequently
worse EM, may display Aβ deposition and have already entered a
preclinical stage of AD. However, the lack of biomarker data in our
study prevents us to draw such a conclusion.
Other brain regions that were identified by the additive model
across the four recall outcomes of the MBT were the bilateral insula and
the dorsal anterior cingulate cortex, both central nodes of the pre-
viously described salience network (Seeley et al., 2007). The insula
displays reciprocal connections with the BFCN (Zaborszky et al., 2015),
and prior studies have highlighted its involvement in performance
Table 4
APOE-ε4 significantly modulated the relationship between delayed retention and regional GMv.
Brain region Laterality t-value⁎ k⁎⁎ MNI coordinates
x y z
Short-delay retention
ε4-dominant Insulaa L 5.05 982 −35 −24 0
Insulaa R 4.90 1261 42 −20 −6
Middle temporal L 4.71 135 −42 −69 11
Inferior frontal R 4.41 220 38 41 18
Hippocampusa R 4.29 732 14 −6 −24
Posterior cingulatea L 4.28 458 −6 −47 26
Hippocampusa L 4.05 908 −24 −14 −20
Inferior parietal L 4.00 118 −27 −54 54
ε4-recessive Entorhinal cortex R 4.10 129 24 −14 −36
ε4-additive Inferior frontal R 4.21 193 39 39 20
Entorhinal cortex R 4.09 323 24 −14 −36
Insula L 4.05 245 −36 −26 0
Insulaa R 3.89 570 35 −23 2
Cerebellum Lob. 8 L 3.84 155 −35 −39 −45
Posterior cingulate L 3.69 119 −9 −48 14
Hippocampus L 3.63 126 −23 −14 −20
Long-delay retention
ε4-dominant Middle cingulatea R 4.51 563 0 −39 41
Inferior parietal L 4.39 359 −26 −53 56
Insula R 4.04 104 42 −20 −6
Posterior cingulate R 4.04 139 0 −56 30
Insula R 3.73 290 32 −27 17
Insula L 3.59 182 −36 −14 14
ε4-recessive Entorhinal cortex R 4.51 201 26 −14 −36
Superior frontal R 3.97 181 9 8 54
Cerebellum Lob. 8 L 3.97 123 −33 −39 −45
ε4-additive Entorhinal cortex R 4.60 206 26 −14 −36
Cerebellum Lob. 8 L 4.12 186 −33 −39 −45
Superior frontal R 4.10 217 9 8 56
Posterior cingulate R 3.91 197 0 −56 30
Insula R 3.57 116 32 −27 17
⁎ Significant at a whole-brain threshold of p < .001. with a cluster size correction of 100 contiguous voxels.
⁎⁎ Cluster size indicated in number of contiguous voxels.
a Additionally survived correction for multiple testing on the cluster level (p < .05) computed with a Family-Wise Error rate approach (FWE).
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monitoring (Cosentino et al., 2015) and error awareness (Klein et al.,
2007). In this framework, our findings suggest that APOE-ε4 carriers
rely on the integrity of multiple compensatory brain systems in order to
achieve an equivalent memory performance to non-carriers, possibly
due to an incipient degeneration of brain areas supporting cognitive
performance (Cacciaglia et al., 2018a: Operto et al., 2018).In line with
this, previous functional MRI studies have consistently show that early-
middle age cognitively healthy APOE-ε4 carriers display
Fig. 3. Effects of the APOE-ε4 risk variant in modifying the association between memory retention and regional gray matter volume.
A) Dominant, recessive and additive effects of APOE-ε4 in modulating the association between short- and long-delay retention (SDR, LDR) and regional gray matter
volume. Significant clusters are projected over coronal slices. B) Group scatterplots in selected brain regions showing the significant interactions between SDR as well
as LDR and APOE-ε4 status in the gray matter volume of hippocampus and entorhinal cortex, respectively. Values of gray matter volume were extracted on the voxel
level (cluster's local maximum) and adjusted for the covariates in the model (i.e., age, sex, years of education and total intracranial volume). Pearson's correlation
coefficients are shown on top of scatterplots for each subgroup. *p < .05, **p < .01, two-tailed. Shaded areas indicate 90% confidence intervals.
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hyperactivation in temporal and frontal areas during episodic as well as
working memory tasks (Filippini et al., 2011; Bondi et al., 2005;
Bookheimer et al., 2000; Wishart et al., 2006) which has been inter-
preted as signature of neural compensation (see Han and Bondi, 2008
for a review). This view is further corroborated by previous studies
which have proposed the BFCN as a substrate for neuronal adaptation.
With this respect, Croxson et al. (2012) found that cholinergic input to
temporal regions facilitates the recovery of function after structural
damage to the circuitry mediating episodic memory. Ray et al. (2015)
showed that patients with MCI present a shift from fornix- to para-
hippocampal-based circuitry in order to preserve their residual
memory, and that this reallocation was dependent on the volume of the
BFCN. The recessive model yielded significant interaction effects pre-
dominantly in midline cortical areas spanning from the dorsal anterior
(TFR, TDPR) to the posterior cingulate gyrus (TPR), including the
precuneus (TFR). For measures of immediate and delayed free recall,
the recessive model also returned significant interactions in the inferior
temporal regions. All these regions are subject to early accumulation of
fibrillary Aβ in healthy APOE-ε4 carriers (Rodrigue et al., 2012) with
these effects being highest in ε4-homozygous (Reiman et al., 2009).
Additionally, lower glucose metabolism in the precuneus and posterior
cingulate cortex has been observed in relation to the number of ε4 al-
leles in cognitively intact individuals (Protas et al., 2013; Reiman et al.,
2005). Thus, our recessive model seems pointing to areas that are
specifically vulnerable to Aβ deposition. Notably, cognitively intact
subjects with cerebral Aβ burden in midline cortical areas display over-
activation in task-positive networks during recall and this hyperactivity
correlates with recall precision, indicating a mechanism of neural
compensation (Elman et al., 2014). It is therefore plausible that a si-
milar mechanism is operating in our ε4-homozygous subjects given the
close association between APOE-ε4 homozygosity and brain amyloi-
dosis. In fact, at the mean age in our sample, about 50% of ε4-homo-
zygous are expected to harbor Aβ pathology (Jansen et al., 2015).
In addition to immediate and delayed recall, we computed the
percentage of retained words after short and long delay with respect to
the number of encoded items. Delayed retention provides different in-
formation compared to recall, because it is controlled for potential
encoding-related effects and it is relatively unaffected by aging
(Brickman et al., 2011). We could confirm that, unlike recall outcomes,
both SDR and LDR were unaffected by advancing age (Supplementary
Fig. 3). Earlier studies have shown that deficient delayed retention
predicts the onset of dementia years before (Lange et al., 2002; Elias
et al., 2000). We did not observe a significant impact of APOE-ε4 on
delayed retention performance, however we did observe interaction
effects similar to that described for recall measures, although with a
partially different topology. For SDR the interaction involved the head
of hippocampus bilaterally, which additionally survived FWE correc-
tion on the cluster level. For LDR we observed a significant interaction
in the right entorhinal cortex. The specificity of delayed retention
measures may have engaged a compensatory strategy in these areas.
Yet, other mechanisms apart from compensation may underlie these
interactions, since SDR and LDR were the only two outcomes of EM
where the homozygote group tended to perform worse than the rest,
possibly indicating an incipient failure of compensatory strategies for
this specific facet of EM (Supplementary Fig. 1).
We next examined EFs and found that APOE-ε4 shifted the asso-
ciation between GMv and performance on cognitive processing speed
(CPS, assessed with the Coding test) as well as working memory (as-
sessed through the digit-span sequencing) from being positive to ne-
gative, again mirroring our previous data on the interaction between
executive functions and aging (Cacciaglia et al., 2018b). Effects for CPS
included orbitofrontal, prefrontal and middle cingulate cortex across
the three genotypic models, although the strongest significance values
were observed in the recessive and additive models where several re-
gions survived FWE correction. CPS efficiency depends on the integrity
of white matter fibers (Borghesani et al., 2013; Kochunov et al., 2010)
and we have recently shown white matter microstructural degeneration
in the homozygote group of the present sample (Operto et al., 2018). It
Table 5
APOE-ε4 significantly modulated the relationship between EFs performance and regional GMv.
Brain region Laterality t-value⁎ k⁎⁎ MNI coordinates
Executive function
Coding
ε4-dominant Lateral orbitofrontala R 4.84 530 39 45 −12
Precentral gyrus L 4.50 193 −39 −6 48
Superior orbitofrontal R 3.85 148 21 38 −15
Medial orbitofrontal L 3.78 101 −21 6 −17
ε4-recessive Medial orbitofrontala L 5.58 1980 −21 6 −17
Lateral orbitofrontala R 5.13 1393 41 44 −11
Precentral gyrusa L 4.78 357 −41 −6 48
Lateral orbitofrontala L 4.45 548 −42 51 −5
Anterior cingulate L 3.95 257 −12 42 2
Middle cingulate R 3.95 200 8 −30 42
Rectal gyrus R 3.63 212 6 35 −14
ε4-additive Lateral orbitofrontal a R 5.36 1339 39 45 −12
Medial orbitofrontala L 5.24 870 −21 6 −17
Precentral gyrusa L 5.01 324 −39 −6 48
Lateral orbitofrontal L 4.46 441 −44 51 −5
Medial orbitofrontala R 4.35 459 21 6 −18
DSS
ε4-recessive Middle orbital gyrus L 4.08 380 −15 54 −14
Caudate nucleus L 3.74 202 −12 8 18
ε4-additive Caudate nucleus L 3.89 279 −14 8 18
Caudate nucleus R 3.53 168 12 11 17
VP
ε4-recessive Postcentral gyrusa L 4.80 620 −27 −44 54
ε4-additive Postcentral gyrusa L 4.38 451 −27 −44 56
Superior frontal L 3.86 180 −17 56 21
MNI: Montreal Neurological Institute; DSS: Digit-span sequencing; VP: Visual puzzles.
⁎ Significant at a whole-brain threshold of p < .001, with a cluster size correction of 100 contiguous voxels.
⁎⁎ Cluster size indicated in number of contiguous voxels.
a Additionally survived correction for multiple testing on the cluster level (p < .05) computed with a Family-Wise Error rate approach (FWE).
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Fig. 4. APOE-ε4 risk variant modulated the associations between cognitive processing speed (CPS) and gray matter volume.
A) Dominant, recessive and additive effects of APOE-ε4 in modulating the association between short- and long-delay retention (SDR, LDR) and regional gray matter
volume. Significant clusters are projected over coronal slices. For visualization purposes parametric maps are thresholded at p < .005 with a cluster extent threshold
of 100 voxels. B) Group scatterplots in selected brain regions showing the significant interactions between CPS performance and APOE-ε4 status. Values of gray
matter volume were extracted on the voxel level (cluster's local maximum) and adjusted for the covariates in the model (i.e., age, sex, years of education and total
intracranial volume). Pearson's correlation coefficients are shown on top of scatterplots for each subgroup. *p < .05, **p < .01, two-tailed. Shaded areas indicate
90% confidence intervals. OFC: Orbitofrontal cortex; MCC: Middle cingulate gyrus.
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is possible that, due to inefficient recruitment of white matter circuitry,
reduced GMv in orbitofrontal areas aids processing speed in APOE-ε4
homozygous. For example, the orbitofrontal cortex is considered a
critical region for motor response inhibition (Bryden and Roesch, 2015;
Rodrigo et al., 2014), hence less volume in these areas would facilitate
or sustain motor activation necessary for this task. Accordingly, a re-
duced volume in the middle cingulate gyrus would disengage conflict
monitoring, supporting the execution of the psychomotor task (Parvaz
et al., 2014; Sohn et al., 2007). In support of this, increased thickness in
frontal areas in healthy APOE-ε4 carriers predicted worse performance
in attentional tasks (Espeseth et al., 2012). Alternatively, larger volume
in prefrontal and orbitofrontal areas in APOE-ε4 homozygotes may be
the result of incipient neuroinflamatory processes exacerbated by the ε4
allele (Wolf et al., 2013), which in turn interferes with efficient ex-
ecutive functions.
Finally, we did not detect a significant impact of APOE-ε4 allele load
on either memory or executive functions, in line with the lack of con-
sistent findings in the literature on the effect of this risk variant on
cognitive performance (O'Donoghue et al., 2018). Genetic epistasis as
well as additional environmental factors may moderate the direct im-
pact of APOE status on cognition and future research shall take these
variables into consideration. As mentioned above, the lack of core AD
biomarkers represents a limitation of the present study. The inclusion of
these data would allow to disentangle whether the observed effects are
further moderated by amyloid or tau positivity. Another limitation is
represented by the cross-sectional nature of our study design. Since
APOE-ε4 has been suggested to impact cognition differentially across
life stages (i.e., the antagonistic pleiotropy hypothesis, reviewed in
Tuminello and Han, 2011), longitudinal follow-up is required to de-
lineate the lifetime trajectories of the interaction effects between cog-
nition and APOE status.
In summary, our study provides novel insights on the mechanisms
through which APOE-ε4 posits an increased risk for AD, by showing that
presence of this risk allele modulates the association between cognitive
function and the underlying gray matter morphology. Even though the
assessed genotypic models revealed overlapping results, several brain
regions were model-specific. However, the additive model was the one
that better summarized the impact of the risk variant on our neuroi-
maging outcomes, as it captured a cerebral topology in conjunction
with either the dominant or the recessive ones. This lends further
support for the previously reported dose-dependent risk for AD exerted
by the APOE-ε4 allele (Corder et al., 1993; Farrer et al., 1997). Finally,
our data suggest that cognitive efficiency may undergo continuous
compensation during healthy aging and in individuals at risk for de-
mentia, making difficult to bridge the gap between genes and cognition
without considering the underlying biological endophenotype. Future
research shall address what factors moderate successful neural com-
pensatory strategies and when this starts to eventually lead to neuro-
degeneration.
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